Search research articles
Contact Us
Filters
Showing results (1-10 of 113) with videos related to
Page
of 12
Sort By:
British Journal of Clinical Pharmacology
|
January 18, 2014
Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets
Ahmed A Othman, Sandeep Dutta
Journal of Clinical Pharmacology
|
January 25, 2018
Population Pharmacokinetics of the TNF-α and IL-17A Dual-Variable Domain Antibody ABT-122 in Healthy Volunteers and Subjects With Psoriatic or Rheumatoid Arthritis: Analysis of Phase 1 and 2 Clinical Trials
Amit Khatri, Ahmed A Othman
Journal of Cardiac Surgery
|
January 25, 2021
Dynamic visceral ischemia in type A dissection
Francesco Torella, Ahmed A Othman, Manoj Kuduvalli
Clinical Pharmacokinetics
|
September 22, 2019
Exposure-Response Analyses of the Effects of Venetoclax, a Selective BCL-2 Inhibitor, on B-Lymphocyte and Total Lymphocyte Counts in Women with Systemic Lupus Erythematosus
Ahmed Nader, Mukul Minocha, Ahmed A Othman
Journal of Clinical Pharmacology
|
February 12, 2024
Feasibility of Using Population Pharmacokinetics-Based Virtual Control Groups in Organ Impairment Studies
Islam R Younis, Fan Wang, Ahmed A Othman
The Journal of Pharmacology and Experimental Therapeutics
|
May 24, 2007
Applicability of the dopamine and rate hypotheses in explaining the differences in behavioral pharmacology of the chloro-benztropine analogs: studies conducted using intracerebral microdialysis and population pharmacodynamic modeling
Ahmed A Othman, Amy Hauck Newman, Natalie D Eddington
Journal of Pharmaceutical Sciences
|
April 22, 2008
The novel N-substituted benztropine analog GA2-50 possesses pharmacokinetic and pharmacodynamic profiles favorable for a candidate substitute medication for cocaine abuse
Ahmed A Othman, Amy H Newman, Natalie D Eddington
Clinical Pharmacokinetics
|
October 28, 2017
Population Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I and II Clinical Trials
Ben Klünder, Mohamed-Eslam F Mohamed, Ahmed A Othman
Clinical Pharmacokinetics
|
December 24, 2019
Clinical Pharmacokinetics of Upadacitinib: Review of Data Relevant to the Rheumatoid Arthritis Indication
Mohamed-Eslam F Mohamed, Ben Klünder, Ahmed A Othman
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 21, 2016
The α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study
George Haig, Deli Wang, Ahmed A Othman, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 113) with videos related to
Sort By:
Page
of 12
British Journal of Clinical Pharmacology
|
January 18, 2014
Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets
Ahmed A Othman, Sandeep Dutta
Journal of Clinical Pharmacology
|
January 25, 2018
Population Pharmacokinetics of the TNF-α and IL-17A Dual-Variable Domain Antibody ABT-122 in Healthy Volunteers and Subjects With Psoriatic or Rheumatoid Arthritis: Analysis of Phase 1 and 2 Clinical Trials
Amit Khatri, Ahmed A Othman
Journal of Cardiac Surgery
|
January 25, 2021
Dynamic visceral ischemia in type A dissection
Francesco Torella, Ahmed A Othman, Manoj Kuduvalli
Clinical Pharmacokinetics
|
September 22, 2019
Exposure-Response Analyses of the Effects of Venetoclax, a Selective BCL-2 Inhibitor, on B-Lymphocyte and Total Lymphocyte Counts in Women with Systemic Lupus Erythematosus
Ahmed Nader, Mukul Minocha, Ahmed A Othman
Journal of Clinical Pharmacology
|
February 12, 2024
Feasibility of Using Population Pharmacokinetics-Based Virtual Control Groups in Organ Impairment Studies
Islam R Younis, Fan Wang, Ahmed A Othman
The Journal of Pharmacology and Experimental Therapeutics
|
May 24, 2007
Applicability of the dopamine and rate hypotheses in explaining the differences in behavioral pharmacology of the chloro-benztropine analogs: studies conducted using intracerebral microdialysis and population pharmacodynamic modeling
Ahmed A Othman, Amy Hauck Newman, Natalie D Eddington
Journal of Pharmaceutical Sciences
|
April 22, 2008
The novel N-substituted benztropine analog GA2-50 possesses pharmacokinetic and pharmacodynamic profiles favorable for a candidate substitute medication for cocaine abuse
Ahmed A Othman, Amy H Newman, Natalie D Eddington
Clinical Pharmacokinetics
|
October 28, 2017
Population Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I and II Clinical Trials
Ben Klünder, Mohamed-Eslam F Mohamed, Ahmed A Othman
Clinical Pharmacokinetics
|
December 24, 2019
Clinical Pharmacokinetics of Upadacitinib: Review of Data Relevant to the Rheumatoid Arthritis Indication
Mohamed-Eslam F Mohamed, Ben Klünder, Ahmed A Othman
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 21, 2016
The α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study
George Haig, Deli Wang, Ahmed A Othman, et al.
Page
of 12